Abstract
Introduction: Suicide is still a major event of human mortality worldwide. Yet human suicide prediction, prevention and therapeutic systems at this moment are generally ineffective in the clinic. No diagnostic system is reliable for significantly suicidal prevention and mortality reduction. As a result, human suicide etiopathologic investigation (especially at genetic/molecular levels in the clinical settings) is quite necessary. In order to boost human suicide researches, emerging human suicide diagnostic/treatment study will be transformed from clinical symptom observations into new generations of candidate drug targets and therapeutics. To achieve this goal, associations between suicidal etiopathologic identification, genetic/bioinformatics-based diagnostics and putative drug targets must be exploited than ever before. After all, the interaction and relationships between environmental/ genetic/molecular clues and overall patient’s risk prediction (environmental influences and different therapeutic targets/types) should be found out.
Conclusion: In the future, effective clinical suicide prediction, prevention and therapeutic systems can be established via scientific expeditions and causality discovery.
Keywords: Bioinformatics, clinical pharmacology, drug development, environmental influence, human genome, human suicide, mental disorders, neural pathogenesis.
Graphical Abstract
Central Nervous System Agents in Medicinal Chemistry
Title:Human Suicide Risk and Treatment Study
Volume: 18 Issue: 3
Author(s): Da-Yong Lu*, Peng-Peng Zhu, Hong-Ying Wu, Nagendra Sastry Yarla, Bin Xu and Ting-Ren Lu
Affiliation:
- Shanghai University, Shanghai 200444,China
Keywords: Bioinformatics, clinical pharmacology, drug development, environmental influence, human genome, human suicide, mental disorders, neural pathogenesis.
Abstract: Introduction: Suicide is still a major event of human mortality worldwide. Yet human suicide prediction, prevention and therapeutic systems at this moment are generally ineffective in the clinic. No diagnostic system is reliable for significantly suicidal prevention and mortality reduction. As a result, human suicide etiopathologic investigation (especially at genetic/molecular levels in the clinical settings) is quite necessary. In order to boost human suicide researches, emerging human suicide diagnostic/treatment study will be transformed from clinical symptom observations into new generations of candidate drug targets and therapeutics. To achieve this goal, associations between suicidal etiopathologic identification, genetic/bioinformatics-based diagnostics and putative drug targets must be exploited than ever before. After all, the interaction and relationships between environmental/ genetic/molecular clues and overall patient’s risk prediction (environmental influences and different therapeutic targets/types) should be found out.
Conclusion: In the future, effective clinical suicide prediction, prevention and therapeutic systems can be established via scientific expeditions and causality discovery.
Export Options
About this article
Cite this article as:
Lu Da-Yong *, Zhu Peng-Peng , Wu Hong-Ying , Yarla Sastry Nagendra , Xu Bin and Lu Ting-Ren , Human Suicide Risk and Treatment Study, Central Nervous System Agents in Medicinal Chemistry 2018; 18 (3) . https://dx.doi.org/10.2174/1871524918666180817093015
DOI https://dx.doi.org/10.2174/1871524918666180817093015 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polypharmacology of <i>Aconitum</i> and <i>Delphinium</i> sp. Diterpene Alka loids: Antiarrhythmic, Analgesic and Anti-Inflammatory Effects
Mini-Reviews in Organic Chemistry Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design Medicinal Properties of Mangiferin, Structural Features, Derivative Synthesis, Pharmacokinetics and Biological Activities
Mini-Reviews in Medicinal Chemistry Propranolol Safety Profile in Children
Current Drug Safety Cloning, Expression and Characterization of Mouse (Mus musculus) Nicotinamide 5-Mononucleotide Adenylyltransferase-2
Medicinal Chemistry Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Purine Molecules as Hypnogenic Factors Role of Adenosine, ATP, and Caffeine
Central Nervous System Agents in Medicinal Chemistry Editorial [ Hot Topic: Antidepressant Drug Design (Executive Editor: Lee E. Schechter)]
Current Pharmaceutical Design Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations
Current Medicinal Chemistry Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
Current Vascular Pharmacology A Review on the Recent Trends in Synthetic Strategies and Applications of Xanthene Dyes
Mini-Reviews in Organic Chemistry Preface:
Central Nervous System Agents in Medicinal Chemistry LncRNA MALAT1 is Neuroprotective in a Rat Model of Spinal Cord Ischemia-Reperfusion Injury Through miR-204 Regulation
Current Neurovascular Research Formulation Approaches of Triptans for Management of Migraine
Current Drug Delivery Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry The Mast Cell Pathway to Inflammation and Homeostasis: Pharmacolo- gical Insights
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cognitive Remediation Therapy of Social Cognition in Schizophrenia: A Critical Review
Current Psychiatry Reviews Coumarin: A Promising Scaffold for Design and Development of Bioactive Agents
Current Bioactive Compounds Partners in Crime: NGF and BDNF in Visceral Dysfunction
Current Neuropharmacology Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1)
Central Nervous System Agents in Medicinal Chemistry